Inspire Medical Systems, Inc. (INSP) Revenue History
Annual and quarterly revenue from 2016 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
INSP Revenue Growth
Revenue Breakdown (FY 2025)
INSP's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
INSP Revenue Analysis (2016–2025)
As of May 9, 2026, Inspire Medical Systems, Inc. (INSP) generated trailing twelve-month (TTM) revenue of $915.2 million, reflecting modest growth of +1.6% year-over-year. The most recent quarter (Q1 2026) recorded $204.6 million in revenue, down 24.0% sequentially.
Looking at the longer-term picture, INSP's 5-year compound annual growth rate (CAGR) stands at +51.2%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $912.0 million in 2025, representing a new all-time high.
Revenue diversification analysis shows INSP's business is primarily driven by Operating Segment (100%). With over half of revenue concentrated in Operating Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including NVCR (+8.5% YoY), TNDM (-6.8% YoY), and IRTC (+27.4% YoY), INSP has underperformed the peer group in terms of revenue growth. Compare INSP vs NVCR →
INSP Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| INSPCurrent | $915M | +1.6% | +51.2% | 5.6% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 TNDM | $1.0B | -6.8% | +15.3% | -7.7% | |
 IRTC | $747M | +27.4% | +23.0% | -4.9% | |
 MDT | $33.5B | +6.9% | +3.0% | 17.8% | |
 ABT | $42.0B | +6.4% | +5.6% | 16.3% |
INSP Historical Revenue Data (2016–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $912.0M | +13.6% | $778.8M | 85.4% | $51.0M | 5.6% |
| 2024 | $802.8M | +28.5% | $679.8M | 84.7% | $36.1M | 4.5% |
| 2023 | $624.8M | +53.2% | $528.2M | 84.5% | $-40,271,000 | -6.4% |
| 2022 | $407.9M | +74.8% | $341.7M | 83.8% | $-47,592,000 | -11.7% |
| 2021 | $233.4M | +102.3% | $200.1M | 85.7% | $-39,850,000 | -17.1% |
| 2020 | $115.4M | +40.6% | $97.8M | 84.7% | $-56,208,000 | -48.7% |
| 2019 | $82.0M | +62.2% | $68.4M | 83.4% | $-34,897,000 | -42.5% |
| 2018 | $50.6M | +77.1% | $40.5M | 80.1% | $-20,378,000 | -40.3% |
| 2017 | $28.6M | +73.9% | $22.5M | 78.9% | $-16,003,000 | -56.0% |
| 2016 | $16.4M | - | $12.5M | 76.2% | $-17,253,000 | -105.0% |
See INSP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs INSP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare INSP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonINSP — Frequently Asked Questions
Quick answers to the most common questions about buying INSP stock.
Is INSP's revenue growth accelerating or slowing?
INSP revenue growth slowed to +1.6%, below the 5-year CAGR of +51.2%. TTM revenue is $915M. The deceleration marks a shift from historical growth rates.
What is INSP's long-term revenue growth rate?
Inspire Medical Systems, Inc.'s 5-year revenue CAGR of +51.2% reflects the variable expansion pattern. Current YoY growth of +1.6% is near this long-term average.
How is INSP's revenue distributed by segment?
INSP reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2016-2025 are available for download. Segment mix reveals concentration and diversification trends.